MarketsandMarkets

Virtual Conference on Liquid Biopsy ( Time Zone - CENTRAL EUROPEAN TIME (CET)

20 -21 May 2020

Understanding the potential of liquid biopsies

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination, monitoring treatment reaction and early diagnostics.

MarketsandMarkets Virtual Conference on Liquid Biopsy will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.

WHAT TO EXPECT

  • Identification of circulating biomarkers for early diagnosis
  • Challenges and advantages to the end-users
  • Advancement in treatment and monitoring of cancer
  • Clinical and non-clinical application of liquid biopsy
  • Recent developments in assays for liquid biopsy
  • Incorporation of Artificial intelligence and machine learning in liquid biopsy

 

Hospitals- Diagnostics Department, Department of clinical oncology, Pathology Labs

Designation- Oncologist, Immunologist, Hematologist, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors

Universities: Designation- Professors, Researchers, Associate professors in Cancer study

Pharma/Therapeutics: Designation- CEO, COO, Senior scientist in cancer and immunology, Research scientist in cancer, Personalized medicine individuals

  • Best networking opportunities with industrial experts from all around the world
  • 100+ experts attending
  • Interactive panel discussions with pioneers of the field
  • Platform to showcase/exhibit innovative technologies
  • Expand on existing organizations and make new networks with across industry and the scholarly community

CONFERENCE AGENDA

Welcome note from MarketsandMarket

02:55 - 03:00

Opening remarks from the Chairman

03:00 - 03:10

FUTURE OPPORTUNITIES AND CHALLENGES FOR USING LIQUID BIOPSY

Keynote Presentation - Viable Single Cell Analysis & Circulating Tumor Cells as Liquid Biopsy in Cancer

DR CATHERINE ALIXPANABIÈRES PhD-

DR CATHERINE ALIXPANABIÈRES PhD- , Director of the Laboratory Rare Circulating Human Cells (LCCRH), l’Université et CHU de Montpellier, France, Europe

03:10 - 03:40

The importance of sensitivity for Residual Disease and Recurrence (RDR) testing

Antony Newton

Antony Newton , VP Business Development, Inivata

03:40 - 04:10

Urine - The Next Generation Early Disease Biomarker Source

Youhe Gao

Youhe Gao, Professor Department of Biochemistry and Molecular Biology, Beijing Normal University

04:10 - 04:40

RECENT DEVELOPMENTS OF LIQUID BIOPSY IN CANCER DETECTION

High Quality Liquid Biopsies- Capture the molecular reality

IMEN EL AMOURI

IMEN EL AMOURI , Team Lead Liquid Biopsy Biobank, Indivumed

04:40 - 04:55

Liquid biopsy for ovarian cancer

JIANYU RAO, M.D

JIANYU RAO, M.D, Vice Chair- Diagnostic Technology Innovation, Director-Cytopathology, Director-International Telepathology Dept. Pathology and Lab Med, UCLA, David Geffen School of Medicine

04:55 - 05:10

Emerging use of liquid biopsies as non-invasive biomarkers: current landscape and future perspectives

Emmanouil Karteris

Emmanouil Karteris, Head of CBCEL, Brunel University London, UK

05:10 - 05:40

One-to-one networking break

05:40 - 06:10

Closing remarks from chairman

06:10 - 06:15

Welcome note from MarketsandMarkets

02:55 - 03:00

Opening remarks from the Chairma

03:00 - 03:10

CLINICAL APPLICATION OF LIQUID BIOPSY AND ASSAYS AVAILABILITY

Keynote Presentation – Blood-based brain injury biomarkers as theranostic tool to accelerate drug development

Kevin Wang

Kevin Wang, Director, Program for Neuroproteomics and Biomarkers Research, University of Florida

03:10 - 03:40

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

Karl J. DSilva

Karl J. DSilva, Medical Director, Clinical Asst. Professor of Medicine, Tufts University School of Medicine, Lahey Hospitals and Medical Center

03:40 - 04:10

FNIH Biomarkers Consortium development of Quality Control Materials for ctDNA Assays

Dana E. Connors

Dana E. Connors, Senior Scientific Project Manager, Cancer Foundation for the National Institutes of Health

04:10 - 04:40

FUTURE OPPORTUNITIES AND CHALLENGES FOR USING LIQUID BIOPSY

Challenges in Using Liquid Biopsy in Clinic

Dr. Harsha Doddihal

Dr. Harsha Doddihal, Clinical researcher, Oncologist, Fortis Hospital

04:40 - 05:10

One-to-one networking break

05:10 - 05:40

Closing remarks from the Chairman

05:40 - 05:45

ENQUIRE NOW

SPEAKERS

Karl J. DSilva

Karl J. DSilva

Medical Director, Clinical Asst. Professor of Medicine, Tufts University School of Medicine, Lahey Hospitals and Medical Center

Dana E. Connors

Dana E. Connors

Senior Scientific Project Manager, Cancer Foundation for the National Institutes of Health

Emmanouil Karteris

Emmanouil Karteris

Head of CBCEL, Brunel University London, UK

Antony Newton

Antony Newton

VP Business Development, Inivata

DR CATHERINE ALIXPANABIÈRES PhD-

DR CATHERINE ALIXPANABIÈRES PhD-

Director of the Laboratory Rare Circulating Human Cells (LCCRH), l’Université et CHU de Montpellier, France, Europe

Jennifer Whittington

Jennifer Whittington

Surgical Oncologist, Queens Hospital Cancer Center

Dr. Harsha Doddihal

Dr. Harsha Doddihal

Clinical researcher, Oncologist, Fortis Hospital

Youhe Gao

Youhe Gao

Professor Department of Biochemistry and Molecular Biology, Beijing Normal University

IMEN EL AMOURI

IMEN EL AMOURI

Team Lead Liquid Biopsy Biobank, Indivumed

Kevin Wang

Kevin Wang

Director, Program for Neuroproteomics and Biomarkers Research, University of Florida

JIANYU RAO, M.D

JIANYU RAO, M.D

Vice Chair- Diagnostic Technology Innovation, Director-Cytopathology, Director-International Telepathology Dept. Pathology and Lab Med, UCLA, David Geffen School of Medicine

SPONSORS

Inivata
RaDar
Indivumed

PAST EVENT GALLERY